- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/62 - PolymyxinsRelated peptides
Patent holdings for IPC class C07K 7/62
Total number of patents in this class: 129
10-year publication summary
|
10
|
13
|
11
|
11
|
10
|
5
|
11
|
4
|
11
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xellia Pharmaceuticals ApS | 92 |
10 |
| Spero Therapeutics, Inc. | 50 |
10 |
| Monash University | 730 |
8 |
| Northern Antibiotics Oy | 6 |
5 |
| MicuRx Pharmaceuticals, Inc. | 10 |
4 |
| New Pharma Licence Holdings Limited | 4 |
4 |
| Northern Antibiotics Ltd. | 6 |
4 |
| Shanghai Micurx Pharmaceutical Co., Ltd. | 21 |
4 |
| Cidara Therapeutics, Inc. | 73 |
3 |
| Universiteit leiden | 202 |
3 |
| Universitat de Barcelona | 311 |
3 |
| The Regents of the University of California | 20815 |
2 |
| Board of Regents, The University of Texas System | 6141 |
2 |
| The Trustees of Columbia University in the City of New York | 3644 |
2 |
| Purdue Research Foundation | 3937 |
2 |
| Auckland UniServices Limited | 497 |
2 |
| Centauri Therapeutics Limited | 16 |
2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 779 |
2 |
| Helperby Therapeutics Limited | 61 |
2 |
| Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 75 |
2 |
| Other owners | 53 |